Scott Gleim
Impact in
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
- Apelin-related biomedical research
Papers in
-
- Receptor Mechanisms and Signaling 8
- Ubiquitin and proteasome pathways 3
- Protein Degradation and Inhibitors 2
- Pharmacology 11
- Inflammatory mediators and NSAID effects 9
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- John Hwa (22 shared papers)Jeremiah Stitham (12 shared papers)Kathleen A. Martin (11 shared papers)Eric Arehart (8 shared papers)Karen Douville (9 shared papers)Wai Ho Tang (5 shared papers)Zsolt Kasza (4 shared papers)Kristina M. Fetalvero (5 shared papers)
- Journals
- PLoS ONE (3 papers)Circulation (2 papers)Journal of Biological Chemistry (2 papers)Journal of Clinical Investigation (2 papers)Circulation Research (2 papers)
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
Scott Gleim
29 papers receiving 878 citations
Peers
Comparison fields: 5 of 80
- Biochemistry 117
- Pharmacology 248
- Cardiology and Cardiovascular Medicine 147
- Internal Medicine 21
- Cellular and Molecular Neuroscience 104
Countries citing papers authored by Scott Gleim
This map shows the geographic impact of Scott Gleim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Gleim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Gleim more than expected).
Fields of papers citing papers by Scott Gleim
This network shows the impact of papers produced by Scott Gleim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Gleim. The network helps show where Scott Gleim may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott Gleim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 129 | |
| 2 | 2011 | 103 | |
| 3 | 2008 | 95 | |
| 4 | 2014 | 95 | |
| 5 | 2015 | 40 | |
| 6 | 2008 | 35 | |
| 7 | 2012 | 33 | |
| 8 | 2017 | 32 | |
| 9 | 2006 | 31 | |
| 10 | 2006 | 26 | |
| 11 | 2007 | 25 | |
| 12 | 2012 | 24 | |
| 13 | 2012 | 24 | |
| 14 | 2017 | 23 | |
| 15 | 2009 | 22 | |
| 16 | 2007 | 21 | |
| 17 | 2009 | 19 | |
| 18 | 2010 | 19 | |
| 19 | 2012 | 17 | |
| 20 | 2020 | 14 |
About Scott Gleim
Scott Gleim is a scholar working on Molecular Biology, Pharmacology, Cellular and Molecular Neuroscience, Cardiology and Cardiovascular Medicine and Oncology, having authored 29 papers that have together received 885 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (9 papers), Receptor Mechanisms and Signaling (8 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Neuropeptides and Animal Physiology (5 papers), Ubiquitin and proteasome pathways (3 papers), Protein Degradation and Inhibitors (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). The work is most often cited by research in Biochemistry (117 citations), Pharmacology (248 citations), Cardiology and Cardiovascular Medicine (147 citations), Internal Medicine (21 citations) and Cellular and Molecular Neuroscience (104 citations). Scott Gleim has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include John Hwa, Jeremiah Stitham, Kathleen A. Martin, Eric Arehart, Karen Douville, Wai Ho Tang, Zsolt Kasza, Kristina M. Fetalvero, Thomas Quertermous and Hyung J. Chun. Their work appears in journals such as PLoS ONE, Circulation, Journal of Biological Chemistry, Journal of Clinical Investigation and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.